A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program
- 31 October 1991
- journal article
- research article
- Published by Elsevier BV in Antiviral Research
- Vol. 16 (3), 213-225
- https://doi.org/10.1016/0166-3542(91)90001-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative studies on the antirhinovirus activity and the mode of action of the rhinovirus capsid binding agents, chalcone amidesAntiviral Research, 1990
- Crystal structure of human rhinovirus serotype 1A (HRV1A)Journal of Molecular Biology, 1989
- Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilizationArchiv für die gesamte Virusforschung, 1989
- Spectral map analysis: Factorial analysis of contrasts, especially from log ratiosChemometrics and Intelligent Laboratory Systems, 1989
- In vitro activity of R 61837, a new antirhinovirus compoundArchiv für die gesamte Virusforschung, 1988
- In vitro antiviral activity of the 6-substituted 2-(3',4'-dichlorophenoxy)-2H-pyrano[2,3-b]pyridines MDL 20,610, MDL 20,646, and MDL 20,957Antimicrobial Agents and Chemotherapy, 1986
- Three-Dimensional Structure of Poliovirus at 2.9 Å ResolutionScience, 1985
- Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410Antimicrobial Agents and Chemotherapy, 1982
- 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compoundNature, 1981
- RMI 15,731 (1-[5-tetradecyloxy-2-furanyl]-ethanone), a new antirhinovirus compoundAntimicrobial Agents and Chemotherapy, 1979